Biomedical Advances for Health Impacts of Nondisordered Drug Use

J Med Internet Res. 2025 Apr 30;27:e65710. doi: 10.2196/65710.ABSTRACTBACKGROUND: Ecological momentary assessment (EMA) is pivotal in longitudinal health research in youth, but potential bias associated...

JAMA Netw Open. 2025 Apr 1;8(4):e257523. doi: 10.1001/jamanetworkopen.2025.7523.ABSTRACTIMPORTANCE: The neuroimmune system represents a promising target for novel medications for alcohol use disorder (AUD). Ibudilast is...

JAMA Netw Open. 2025 Apr 1;8(4):e257803. doi: 10.1001/jamanetworkopen.2025.7803.ABSTRACTIMPORTANCE: Rapidly acting therapeutics like 3,4-methylenedioxymethamphetamine (MDMA) are promising treatments for disorders such as posttraumatic stress disorder (PTSD)....

JAMA Psychiatry. 2025 Apr 30. doi: 10.1001/jamapsychiatry.2025.0569. Online ahead of print.ABSTRACTIMPORTANCE: It remains unknown whether difficulties in positive emotion regulation (ER) drive opioid use disorder...

Pharmacol Rep. 2025 Apr 30. doi: 10.1007/s43440-025-00730-9. Online ahead of print.ABSTRACTBACKGROUND: Ketamine is currently gaining attention as a rapid-acting antidepressant for treatment-resistant depression (TRD). However,...

Acad Psychiatry. 2025 Apr 30. doi: 10.1007/s40596-025-02148-0. Online ahead of print.NO ABSTRACTPMID:40304979 | DOI:10.1007/s40596-025-02148-0